Bach1 deficiency reduces severity of osteoarthritis through upregulation of heme oxygenase-1 by unknown
RESEARCH ARTICLE Open Access
Bach1 deficiency reduces severity of
osteoarthritis through upregulation of
heme oxygenase-1
Tsuyoshi Takada1*, Shigeru Miyaki1,2, Hiroyuki Ishitobi2, Yuya Hirai1, Tomoyuki Nakasa1, Kazuhiko Igarashi3,
Martin K. Lotz4 and Mitsuo Ochi1
Abstract
Introduction: BTB and CNC homology 1 (Bach1) is a transcriptional repressor of Heme oxygenase-1 (HO-1), which
is cytoprotective through its antioxidant effects. The objective of this study was to define the role of Bach1 in
cartilage homeostasis and osteoarthritis (OA) development using in vitro models and Bach1-/- mice.
Methods: HO-1 expression in Bach1-/- mice was analyzed by real-time PCR, immunohistochemistry and
immunoblotting. Knee joints from Bach1-/- and wild-type mice with age-related OA and surgically-induced OA were
evaluated by OA scoring systems. Levels of autophagy proteins and superoxide dismutase 2 (SOD2) were
determined by immunohistochemistry. The relationship between HO-1 and the protective effects for OA was
determined in chondrocytes treated with small interfering RNA (siRNA) targeting HO-1 gene.
Results: HO-1 expression decreased with aging in articular cartilages and menisci of mouse knees. Bach1-/- mice
showed reduced severity of age-related OA and surgically-induced OA compared with wild-type mice. Microtubule-
associated protein 1 light chain 3 (LC3), autophagy marker, and SOD2 were increased in articular cartilage of
Bach1-/- mice compared with wild-type mice. Interleukin-1β (IL-1β) induced a significant increase in Adamts-5 in
wild-type chondrocytes but not in Bach1-/- chondrocytes. The expression of SOD2 and the suppression of apoptosis
in Bach1-/- chondrocytes were mediated by HO-1.
Conclusions: Bach1 deficiency reduces the severity of OA-like changes. This may be due to maintenance of
cartilage homeostasis and joint health by antioxidant effects through HO-1 and downregulation of extracellular
matrix degrading enzymes. These results suggest that inactivation of Bach1 is a novel target and signaling pathway
in OA prevention.
Introduction
Osteoarthritis (OA), the most prevalent aging-related
joint disease, is characterized by degradation of articular
cartilage and alterations in other joint tissues. The most
important risk factors are aging, obesity, mechanical
stress, and inflammation, and these factors impair tissue
homeostasis through dysregulation of intracellular signal-
ing mechanisms and extracellular matrix (ECM) remodel-
ing [1, 2]. The interaction of aging-associated changes in
cartilage and molecular mechanisms of OA pathogenesis
remains to be elucidated. Oxidative stress has been
established as an important factor as it is elevated in joint
tissues including articular cartilage in aging and OA [3–5].
Increased oxidative stress results from increased reactive
oxygen species (ROS) generation and from reduced anti-
oxidants, and is accompanied by a progressive accumula-
tion of damaged molecules and organelles, leading to
activation of catabolic factors such as inflammatory cyto-
kines and extracellular matrix (ECM)-degrading proteases
[1, 2]. Antioxidant enzymes such as Heme oxygenase-1
(HO-1) and superoxide dismutase 2 (SOD2) are an im-
portant defense against ROS-mediated damage [6, 7].
HO-1 promotes iron recycling by degrading heme into
ferrous iron, carbon monoxide and biliverdin, and protects
cells from various stresses [6, 8]. Previous studies revealed
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that induction of HO-1 has beneficial effects in several
diseases [9–11]. The expression of HO-1 gene (Hmox-1)
is negatively regulated by BTB and CNC homology 1
(Bach1), a transcriptional repressor, which binds to Hmox-1
enhancers. Bach1 deficient mice thus have high constitutive
HO-1 expression in various tissues under physiological
conditions [12]. These mice have reduced disease severity
in several injury models [13–15] and age-related degener-
ation of the meniscus [16]. However, potential beneficial ef-
fects of HO-1 in OA development have not been
determined. The objectives of this study were to investigate
the impact of Bach1 deficiency on two different animal
models of OA, an aging model, primary OA, and a surgical
model, posttraumatic OA.
Methods
Animal models of OA
Bach1-/- mice on C57BL/6 background were described
previously [12]. Only male mice were used in this study.
All animal experiments were performed according to pro-
tocols approved by Hiroshima University Animal care and
Use Committee. Knee joints were harvested at 6 months
(n = 7), 12 months (n = 11), and 22 months (n = 14) to
monitor spontaneous age-related OA. Experimental OA
was induced in 10 week-old, wild-type mice (n = 13) and
Bach1-/- mice (n = 11) by transection of the medial menis-
cotibial ligament (MMTL) and the medial collateral liga-
ment (MCL) in the right knees [17]. Mice were sacrificed
8 weeks after surgery, and the knee joints were collected
for histological analysis.
Histological assessments
All knee joints were embedded intact in paraffin after
fixation in 4 % Paraformaldehyde Phosphate Buffer
Solution and decalcification in K-CX (FALMA, Tokyo,
Japan). Knee joints sectioned (4.5 μm) in the sagittal
plane through the central weight-bearing region of the
medial and lateral femorotibial joint. The sections were
stained with Safranin O/fast green and at least two dif-
ferent sections per sample were analyzed microscopic-
ally. In this study, we applied multiple separate scoring
systems for articular cartilage, meniscus, synovitis, osteo-
phyte formation and subchondral bone thickening.
Osteoarthritic damage of articular cartilage was scored
using a modified Mankin system [18, 19]. Meniscus deg-
radation was evaluated using a scoring system [20] which
included the following 6 criteria, meniscus integrity (0 =
smooth surface, 1 = irregularity of superficial layer or
slight fibrillation, 2 =moderate fibrillation, 3 = severe
fraying, tear or disruption), collagen structure (0 = normal,
1 = slight disturbance, 2 =moderate disturbance, 3 = se-
vere disturbance or mucoid substances), cellular abnor-
malities (0 = normal, 1 = hypercellularity, 2 = cloning
tendency, 3 = hypocellularity), stainability of safranin O
staining (0 = normal, 1 = slight reduction, 2 =moderate re-
duction, 3 = severe reduction), calcification and cyst for-
mation (0 = normal, 1 = slight, 2 =moderate, 3 = severe).
The maximum possible score per meniscus was 18.
Osteophyte formation and subchondral bone thickening
were scored on a scale of 0–3, where 0 = normal, 1 =mild,
2 =moderate and 3 = severe changes, and the average
scores for tibia and femur were recorded. The severity of
synovitis was evaluated according to a previously de-
scribed histopathological classification system [21]. The
parameters of synovitis included hyperplasia/enlargement
of synovial lining layer, degree of inflammatory cell infil-
tration and activation of resident cells/synovial stroma. All
parameters were graded from 0 (absent), 1 (slight), 2
(moderate) to 3 (strongly positive) and summarized ran-
ging from 0–9, where 0–1 corresponds to no synovitis
(grade = 0), 2–3 to a slight synovitis (grade 1), 4–6 to
moderate synovitis (grade 2), and 7–9 to severe synovitis
(grade 3).
Immunohistochemical analysis
Knee joint sections were immunostained with anti-HO-1
antibody (1:75, ab52947, Abcam, Austin, TX, USA)
using Vectastain ABC-AP alkaline phosphatase (Vector
Laboratories, Burlingame, CA, USA) as described pre-
viously [22]. For anti-microtubule-associated protein 1
light chain 3 (LC3) antibody (1:100, AP1801a,
ABGENT, San Diego, CA, USA), anti-manganese
superoxide dismutase (MnSOD) antibody (1:100, SPC-
117, StressMarq, Victoria, BC, Canada), sections in Immu-
noactive pH 6.0 (Matsunami Glass, Osaka, Japan) were
heated in a microwave oven and kept at 85 °C for 1.5 mi-
nutes. Slides were cooled for 20 minutes at room
temperature after antigen unmasking. After washing with
PBS, 3 % H2O2 treated for 10 minutes, sections were
blocked with 10 % serum for 20 minutes at room
temperature. Antibodies were applied and incubated over-
night at 4 °C. After washing with PBS, sections were incu-
bated with biotinylated secondary antibody for 30 minutes
at room temperature and then incubated using the perox-
idase based Elite ABC system (Vector Laboratories) for
30 minutes. Slides were washed, and sections were incu-
bated with 3,3 -diaminobenzidine (DAB) substrate.
Isolation and culture of mouse articular chondrocytes
Primary articular chondrocytes were dissected from the
femoral heads of 1-month-old Bach1-/- and wild-type mice
by digestion with 0.3 % collagenase Type 2 (Worthing-
ton, Lakewood, NJ, USA) in Dulbecco’s modified Eagle’s
medium (DMEM) (Wako, Osaka, Japan) for 2 h. Isolated
chondrocytes were cultured in DMEM with 10 % fetal bo-
vine serum.
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Transfection of small interfering RNA into mouse
articular chondrocytes
Articular chondrocytes from wild-type mice and Bach1-/-
mice were seeded at 5 × 104 cells/well on a 24-well plate
and were transfected with small interfering RNA
(siRNA) for HO-1 using Lipofectamine RNAiMax
Reagent (Invitrogen, Carlsbad, CA, USA). The sequences
of the siHO-1 were: (sense) 5′- CAACAGUGGCAG
UGGGAAUTT -3′ and (antisense) 5′- AUUCCCACUG
CCACUGUUGTT-3′ (Hokkaido System Sciences,
Hokkaido, Japan). Control siRNAs were also prepared
for the control group (siRNA negative control; siNega
#1, Invitrogen). At 24 h after transfection, articular chon-
drocytes were treated with IL-1β (1 ng/ml; Pepro-
Tech, Rocky Hill, NJ, USA) for an additional 24 h.
Quantitative real-time polymerase chain reaction (PCR)
Total RNA was extracted from chondrocytes using TRIzol
Reagent (Invitrogen). Complementary DNA (cDNA) was
synthesized using 500 ng of total RNA with the Super-
Script VILO cDNA Synthesis Kit (Invitrogen). A real-time
PCR assay was performed using TaqMan Gene Expression
Assay probes (Applied Biosystems, Foster City, CA, USA) to
amplify the Bach1 (Mm01344527), Hmox-1 (Mm00516005),
Col2a1 (Mm01309565_m1), Acan (Mm00545807), Mmp-13
(Mm01168713), Adamts-5 (Mm01344182_m1), and Sod2
(Mm01313000_m1), and Gapdh (Mm99999915_g1) was
used as the internal control to normalize the sample differ-
ences. Relative expression was calculated using the ΔΔCt
values, and results were expressed as 2-ΔΔCt.
DNA microarray analysis
DNA microarray (TORAY, Tokyo, Japan, 3D-Gene, Mouse
Oligo chip 24 k) analysis was performed using total RNA
from chondrocytes from wild-type mice and Bach1-/- mice.
Immunoblotting assay
For immunoblotting, proteins were extracted from cul-
tured chondrocytes using M-PERTM protein extraction
reagent including protease inhibitor cocktail (Thermo
Fisher Scientific, Waltham, MA, USA). Anti-HO-1 anti-
body (diluted 1:2000), anti-LC3 antibody (diluted
1:1000), and anti-MnSOD antibody (diluted 1:1000) were
used as primary antibodies. Horseradish peroxidase
(HRP)-conjugated goat anti-rabbit immunoglobulin G
(IgG) antibody (sc-2030; Santa Cruz Biotechnology,
Dallas, TX, USA) and anti-mouse IgG antibody (sc-2005;
Santa Cruz Biotechnology) were used as secondary anti-
body. The signal was detected with chemiluminescence
of enhanced immuno-enhancer (Wako, Osaka, Japan)
using the ImageQuant LAS 4000 system (GE Healthcare,
Uppsala, Sweden).
Apoptosis assay
Articular chondrocytes were seeded at 1.5 × 104 cells/
well on 96-well plates and transfected with siHO-1 or
siRNA negative control. Articular chondrocytes were
treated with tert-butyl hydroperoxide (t-BHP) (200 uM;
Wako) for 5 h at 24 h after transfection. Apoptotic
chondrocytes were quantitated by counting the numbers
of cell nuclei stained with Cell Event Caspase-3/7 Green
Detection ReagentTM and NucBlue Live cell stain Ready-
ProbesTM (Invitrogen) in three random fields on each
duplicate well at a magnification of × 10 under a fluores-
cence microscope (BZ-9000; Keyence, Osaka, Japan).
Statistical analysis
The data were analyzed using the Mann–Whitney U test,
Steel or Steel–Dwass to determine statistical differences.
Differences were considered statistically significant at
P <0.05 (*) and P <0.01 (**).
Results
Expression of HO-1 in articular cartilage
To examine the genes regulated by Bach1, DNA micro-
array analysis was performed on articular chondrocytes
of wild-type mice and Bach1-/- mice. The results showed
that expression of 34 mRNAs was increased more than
three-fold in Bach1-/- articular chondrocytes, and only
Hmox1 was among the top 20 differentially expressed
genes and highly expressed genes in Bach1-/- chondro-
cytes (Table 1). The expression of HO-1 gene and protein
were significantly increased in Bach1-/- chondrocytes com-
pared with wild-type chondrocytes (Fig. 1a, b). Studies to
further evaluate the phenotype of Bach1-/-articular chon-
drocytes from 1-month-old mice observed a decrease
in Col2a1 and Acan with a simultaneous increase in
Mmp-13. However, these differences were not signifi-
cantly different between Bach1-/- and wild-type chon-
drocytes (Fig. 1c), and articular cartilages from
Bach1-/- mice at 1 month of age did not have reduced
Safranin O staining (data not shown). Furthermore,
we evaluated the expression of HO-1 in knee joints
from 22-month-old mice. Articular cartilage and me-
niscus in Bach1-/- mice had significantly more HO-1
positive cells than wild-type mice (Fig. 1d).
Expression of HO-1 in articular cartilage with aging
To examine aging-related changes in HO-1 expression
in mouse knee joints, we performed immunohistochemi-
cal analysis. HO-1 was expressed in chondrocytes in the
articular cartilage and the menisci in knee joints from
wild-type mice at 3 months of age (Fig. 2a). By
12 months of age, HO-1 expression was substantially re-
duced to only a subset of cells in the superficial zone of
cartilage (Fig. 2a). In 22-month-old mice that did not
have structural cartilage defects, HO-1 staining in
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articular cartilage was no longer detectable, with the ex-
ception of a few cells at the joint margin (Fig. 2a). Thus,
there is a significant reduction in HO-1 positive cells
with aging in the articular cartilages (Fig. 2b).
Reduced severity of osteoarthritis in Bach1-/- mice
Skeletal development in Bach1-/- mice was normal.
There were no differences in overall joint architecture or
changes in the articular cartilage and growth plate. The
body weight of Bach1-/- mice was not significantly differ-
ent at 4 and 10 weeks, however, at 22 months it was sig-
nificantly lower than in wild-type mice (Fig. 3a). To
examine whether Bach1 affected age-related OA devel-
opment, spontaneous osteoarthritic changes in the knee
joints from Bach1-/- and wild-type mice were evaluated
at 6, 12 and 22 months of age. From 1 to 6 months of
age, both strains of mice had intact articular cartilage
and similar proteoglycan staining (data not shown). At
12 months of age, wild-type mice had a reduction in
proteoglycan. OA severity in wild-type mice at
22 months of age ranged from minimal changes to car-
tilage fibrillation or partial and full-thickness defects
with exposure of subchondral bone. These changes were
significantly less severe in Bach1-/- mice (Fig. 3b). Wild-
type mice also exhibited meniscus degradation, inflam-
matory changes in synovium, osteophyte formation and
subchondral bone thickening. Semiquantitative scoring
systems also indicated a significant decrease in the sever-
ity of OA-like changes in all joint tissues in Bach1-/-
mice at 22 months of age compared with the wild-type
mice (Fig. 3c). Next, we used the surgical OA model
with transection of MMTL and MCL in 10-week-old
mice. Consistent with observations in the aging OA
model, the surgical OA model demonstrated signifi-
cantly reduced articular cartilage scores in Bach1-/- mice
(Fig. 3d). Although the severity of meniscus degradation
was accelerated by transection of the MMTL, meniscus
degradation was significantly different between the wild-
type and Bach1-/- mice. However, inflammatory changes
in synovium were not significantly different (Fig. 3e).
SOD2 and LC3 expression in articular cartilage of
aged mice
SOD2 and autophagy are essential cellular homeosta-
sis mechanisms and protect against aging-related
diseases [23]. To determine whether the increase in
HO-1-positive cells in articular cartilage was associ-
ated with changes in SOD2 expression and autophagy,
the expression of SOD2 and LC3, a main marker of
autophagy, was characterized by immunohistochemis-
try. At 12 and 22 months of age, Bach1-/- mice
Table 1 Gene expression in chondrocytes from Bach1-/- mice
Top 20 Symbol Ratio (Bach1-/- : wild) Top 20 Symbol Normalized expression level
1 LOC635992 5.82 1 Fth1 23704
2 Mllt3 5.79 2 Ftl2 21177
3 4930481F22Rik 4.69 3 mt-Nd1 18945
4 Unknown 4.31 4 Fn1 18837
5 Tnfrsf26 4.29 5 unknown 18423
6 Nlrp4d 4.19 6 Rps3a 18007
7 Ly9 4.06 7 Ubb 17696
8 V1re10 4.01 8 Vim 17167
9 V1rh21 3.64 9 unknown 17069
10 Hmox1 3.63 10 Rpl35 16832
11 Lefty2 3.6 11 Gapdh 16831
12 Cdkl3 3.58 12 Col2a1 16623
13 Unknown 3.55 13 Ubb 16615
14 4933407L21Rik 3.52 14 unknown 16589
15 Arhgap4 3.5 15 Hmox1 16534
16 Serpina1f 3.43 16 EG432768 16487
17 Xmr 3.38 17 Tpt1 16335
18 Gldn 3.35 18 Ftl1 15922
19 Ckt2 3.35 19 Rpl32 15662
20 Hmgb1l 3.34 20 Ppia 15642
Total RNA was isolated from articular chondrocytes in wild-type and Bach1-/- mice. Left side: top 20 of differentially expressed genes are shown as the ratio of
chondrocytes in Bach1-/- mice to chondrocytes in wild-type mice. Right side: the 20 genes of the highest expression level in chondrocytes from Bach1-/- mice
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showed significantly increased numbers of SOD2- and
LC3-positive chondrocytes compared with wild-type
mice (Fig. 4a). Bach1-/- mice also showed increased
numbers of SOD2- and LC3-positive cells as com-
pared to wild-type mice in the surgical OA model
(Fig. 4b). These results suggest that articular cartilage
in Bach1-/- mice maintained not only HO-1 but also
expression of SOD2 and the autophagy marker LC3
in the surgical and the aging-related OA model.
The role of HO-1 and Bach1 in SOD2 and LC3 expression
in mouse chondrocytes
The expression of both SOD2 and LC3 increased during
aging in articular cartilage of Bach1-/- mice compared
with wild-type mice, similar to HO-1 (Fig. 4). Thus, to
elucidate the relation between Bach1, HO-1 and SOD2,
LC3, articular chondrocytes from wild-type and Bach1-/-
mice were treated with siHO-1 or negative control
siRNA. Expression SOD2 was significantly greater in
chondrocytes from Bach1-/- mice at 1 month of age
(Fig. 5a). Furthermore, the increased SOD2 expression
in Bach1-/- mice was reduced by HO-1 knockdown
(Fig. 5a). LC3 expression was not significantly different
between wild-type and Bach1-/- chondrocytes with or
without siHO-1 (data not shown). We also examined
key enzymes in OA cartilage degradation, Mmp-13 and
Adamts-5 in IL-1β-treated Bach1-/- chondrocytes. IL-1β
induced a significant increase in Adamts-5 in wild-type
Fig. 1 Expression of heme oxygenase-1 (HO-1) in articular cartilages from wild-type (WT) mice and Bach1-/- mice. Primary articular chondrocytes were
isolated from mouse femoral head cartilage (n = 4 per group) at the age of 1 month. a Real-time PCR assay for Hmox1. b Western blot analysis of
HO-1 protein (n = 4). c Evaluation of the phenotype of articular chondrocytes in Bach1-/- mice. Expression of cartilage-associated genes was determined
by real-time PCR assay (n = 4 per group). d Comparison of HO-1 expression in articular cartilage from 22-month-old wild-type mice and Bach1-/- mice
(n = 4 per group). Knee joints were assessed by immunohistochemistry using anti-HO-1 antibody. Original magnification × 10 (left; scale bars 200 μm,
and × 20 (right; scale bars 100 μm). Values in a, c and d were expressed as means ± SD. Statistical analysis was performed with the Mann–Whitney U
test; **P <0.01
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chondrocytes but not in Bach1-/- chondrocytes. There
were trends towards increased Mmp-13 in IL-1β-treated
wild-type chondrocytes but not in Bach1-/- chondro-
cytes. Furthermore, their expression was not directly
regulated by HO-1 because the knockdown of HO-1 did
not significantly affect expression of these genes (Fig. 5b).
Bach1-/-mouse chondrocytes had significantly decreased
numbers of caspase-3/7-positive cells following treatment
with the oxidant t-BHP. Compared with wild-type
mice, the number of positive cells was significantly
increased in chondrocytes treated with siHO-1
(Fig. 5c). These results suggest that upregulated
SOD2 and the suppression of apoptosis in Bach1-/-
chondrocytes were mediated by HO-1.
Discussion
In aging and OA, oxidative stress is elevated in joint tis-
sues including cartilage [4]. The antioxidant enzyme
HO-1 mediates general adaptive responses and provides
enhanced resistance to various stresses. HO-1 is negatively
regulated by Bach1, a transcriptional repressor. Bach1 is
induced by transforming growth factor β (TGF-β), and is
inactivated by oxidative stress, binding of heme, and oxi-
dation of cysteine residue [12, 24–26]. HO-1 was
markedly decreased in articular cartilage with aging in
wild-type mice. These results suggest that maintenance of
HO-1 expression has potential to protect against OA
development and aging.
In the present study, Bach1-/- mice exhibited highly in-
creased HO-1 expression even in articular cartilage of
aged mice and reduced severity of age-related OA-
like changes. However, Bach1 deficiency and accom-
panying overexpression of HO-1 did not influence
aging and life span [27]. Inflammation and obesity
generally increase with aging. Our study showed that
weight of Bach1-/- mice were lower than wild-type
mice at 22 months old. Thus, although the decreased
weight of aged Bach1-/- mice may contribute to joint
health through metabolic changes, the level of proin-
flammatory cytokines in serum was not significant
different between wild-type mice and Bach1-/- mice at
22 months old (data not shown). Previously, it was
reported that inflammatory diseases are less severe in
Bach1-/- mice, in part through increased HO-1 in
macrophages [28]. In a similar fashion, bone destruc-
tion is attenuated in Bach1-deficient mice via altered
osteoclastogenesis [29]. The induction of HO-1 also
results in protective effects against inflammatory and
degradative responses in OA chondrocytes and OA
synoviocytes [30–32]. Thus, the reduced severity of
Fig. 2 Expression of heme oxygenase-1 (HO-1) in knee joints in aging and osteoarthritis (OA). a Knee joints from 3-month- (3 M), 12-month (12 M)
and 22-month (22 M)-old wild-type mice (n = 3–4 per group) were collected and the sections were assessed by immunohistochemistry. Original
magnification × 10; scale bars 200 μm. b Values are expressed as means ± SD. Statistical analysis was performed with the Steel–Dwass test; *P <0.05
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OA-like changes in Bach1-/- mice might occur
through suppression of inflammation by higher con-
stitutively expressed HO-1 in various cells, including
chondrocytes. In aged mice and the surgical OA
model, however, the level of proinflammatory
cytokines in serum was not significantly different be-
tween wild-type mice and Bach1-/- mice. In addition,
the level of proinflammatory cytokines in serum from
Bach1-/-mice was increased post-surgically compared
with pre-surgical levels in the same mice (data not
Fig. 3 Bach1-/- mice have reduced severity of osteoarthritis (OA) in an aging model and a surgical OA model. a Body weight of wild-type mice
and Bach1-/- mice at 4 (4 W) and 10 weeks (10 W) and 22 months (22 M) (n = 5–9 animals per time point). b Histological assessment using
modified Mankin scoring system of spontaneous cartilage degeneration exacerbated with aging in wild-type mice and Bach1-/- mice. Photographs
of a knee from a representative mouse at 22 months old, from each group are also shown. Original magnification × 10; scale bars 200 μm. c Analyses
of OA pathology using the semiquantitative scoring system in mice at 22 months old, including synovitis, osteophyte formation, subchondral bone
thickening and meniscus degradation. Original magnification × 20; scale bars 100 μm. d Analyses of cartilage pathology in a surgically induced OA
model. Original magnification × 20; scale bars 100 μm. e Analyses of OA pathology in a surgically induced OA model, including synovitis, osteophyte
formation, subchondral bone thickening and meniscus degradation. Original magnification × 20; scale bars 100 μm. Values are the mean ± SD.
Statistical analysis was performed with the Mann–Whitney U test; *P <0.05, **P <0.01 versus wild-type mice
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shown). Thus, in spite of increased proinflammatory
cytokines in Bach1-/- mice with surgical OA, the OA-
like changes were attenuated, indicating that the re-
duction of OA-like changes in Bach1-/- mice may be
not only due to the anti-inflammatory effect of HO-1
upregulation.
SOD2 and autophagy also are key mediators of aging-
related diseases and prevent the accumulation of defect-
ive mitochondria that produce high levels of ROS in
chondrocytes [23]. SOD2 is the main antioxidant en-
zyme that scavenges superoxide anions in the inner
mitochondrial matrix [33]. Autophagy has important
anti-aging functions and reduces aging-associated cell
death, dysfunction, and disease [34]. Recently, it was re-
ported that SOD2 is reduced during OA development and
in aging [5, 35], and autophagy decreased in articular
cartilage of human OA, aging-related and surgically-
induced OA in mice [36]. Autophagy is involved in
maintenance of articular cartilage homeostasis, and re-
duces severity in mouse OA models [22, 37]. In the
present study, Bach1-/- mice maintained the expres-
sion of SOD2 and LC3 in articular cartilage, as well
as HO-1. Although the upregulated LC3 expression in
Bach1-/- mice was not significantly reduced by HO-1
knockdown, SOD2 was regulated by HO-1. Chondrocyte-
specific deletion of SOD2 in human cells and mice
accelerates OA-like changes accompanied by oxidative
damage and mitochondrial dysfunction [38]. Thus,
maintenance of SOD2 in chondrocytes also may be
important for OA prevention. While increased Mmp-
Fig. 4 Expression of microtubule-associated protein 1 light chain 3 (LC3) and superoxide dismutase 2 (SOD2) in articular cartilage. Knee joints from
wild-type (WT) mice and Bach1-/- mice were analyzed by immunohistochemistry for LC3 and SOD2. Total number of LC3- and SOD2-positive cells
in six fields were counted and the percentage of positive cells was calculated. a Representative immunostaining of articular cartilage from
12-month- (12 M) and 22 month (22 M)-old mice (aging model) (n = 4 per group). b Representative immunostaining of articular cartilage
from a surgically induced osteoarthritis (OA) model (n = 4 per group). Original magnification × 20; scale bars 100 μm. Values are the mean ± SD.
Statistical analysis was performed with the Mann–Whitney U test; *P <0.05, **P <0.01 versus wild-type mice
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13, Adamts-5 and apoptosis, key OA-related factors,
were suppressed in Bach1-/- mouse chondrocytes
under stress, only apoptosis was significantly regulated
by HO-1. Our findings indicate that the protective effects
against OA development in Bach1-/- mice appear to be
antioxidant activity and cytoprotective effects through
HO-1 in chondrocytes and downregulation of ECM-
degrading enzymes. Thereby, Bach1 deficiency coordi-
nates maintenance of cartilage homeostasis and joint
health.
Our observations suggest that inducers of HO-1 may
be effective therapeutic agents for OA prevention. Local
gene delivery of HO-1 into the mouse knee joint results
in transduction of the joint tissues such as synovium, ex-
cept for cartilage, however, it does not reduce OA-like
changes [39]. This result suggests that the expression of
HO-1 in cartilage is important for the protection and
the treatment of OA. Thus, the pharmacological inhib-
ition of Bach1 and induction of HO-1 in cartilage might
have potential in the prevention or treatment of OA.
Fig. 5 The involvement of heme oxygenase-1 (HO-1) in changes observed in Bach1-/- articular chondrocytes. Small interfering HO-1 (siHO-1) or
control siRNA (10 uM) was transfected into chondrocytes from wild-type (WT) and Bach1-/- mice at 1 month of age (n = 4 per group).
a The expression of superoxide dismutase 2 (SOD2) protein was detected by immunoblot analysis. Values are the mean ± SD. Statistical
analysis was performed with the Steel–Dwass test; *P <0.05 versus wild-type chondrocytes. b The expression of Mmp-13 and Adamts-5 in
Bach1-/- chondrocytes with IL-1β (1 ng/ml) for 24 h. Values are the mean ± SD. Statistical analysis was performed with the Steel test;
*P <0.05 versus wild-type chondrocytes (-IL); #P <0.05 versus Bach1-/- chondrocytes (-IL). c Caspase-3/7 was detected in wild-type and
Bach1-/- mouse chondrocytes with or without the oxidant tert-butyl hydroperoxide (t-BHP) (200 uM) for 5 h. Values are the mean ± SD.
Statistical analysis was performed with the Steel–Dwass test; *P <0.05, **P <0.01 versus wild-type chondrocytes with t-BHP; ##P <0.01
versus Bach1-/- chondrocytes treated with t-BHP. GAPDH glyceraldehyde–3–phosphate dehydrogenase
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Conclusions
Bach1-/- mice have reduced severity of OA in aging and
surgical models and this is at least in part mediated
through regulation of HO-1, ECM degrading enzymes
and chondrocyte viability. These findings suggest that
approaches to reduce Bach1 expression have potential as
a novel therapeutic approach.
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